md_biochemistry

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
md_biochemistry [2026/06/26 13:25]
admin
md_biochemistry [2026/09/22 06:19] (current)
resident
Line 26: Line 26:
 |22|:::|Instrument Purchase Vs Reagent rental/Cost per test|{{ ::2._mercury_blood_spillage.pptx |Spillage Management}} | |22|:::|Instrument Purchase Vs Reagent rental/Cost per test|{{ ::2._mercury_blood_spillage.pptx |Spillage Management}} |
 |23|:::|Inventory Management System|{{ ::11._qms.pptx |QMS}}| |23|:::|Inventory Management System|{{ ::11._qms.pptx |QMS}}|
-|23|:::|Isoenzyme|{{ ::11._qms.pptx |QMS}}| +|24|:::|Isoenzyme|{{ ::11._qms.pptx |QMS}}| 
-|24|<html><span style="font-size:150%;">Dr Arvi Mehta</span></html> |NABL-133|  +|25|<html><span style="font-size:150%;">Dr Arvi Mehta</span></html> |NABL - 133|{{ ::use_and_implementation_of_nabl_symbol_as_per_nabl_-_133_in_medical_testing_laboratories.pptx |Use and Implementation of NABL Symbol as per NABL - 133 in Medical Testing Laboratories}}|  
-|25|:::| |  +|26|:::|FTIR|{{ ::ftir.pptx |FTIR-Principle}}|  
-|26|:::| |  +|27|:::|Quality Policy vs Quality Objective|{{ ::quality_policy_vs_quality_objective_in_context_of_iso_151892022.pptx |Quality Policy vs Quality Objective in Context of ISO 151892022}}|  
-|27|:::| |  +|28|:::|VLDL Metabolism|{{ ::vldl_metabolism.pptx |VLDL Metabolism}}|  
-|28|:::| |  +|29|:::|D-Dimer|{{ ::d-dimer.pptx |D-Dimer}}| 
-|29|:::| | +
 |30|:::| |  |30|:::| | 
 |31|:::| |  |31|:::| | 
-|24|<html><span style="font-size:150%;">Dr Jahnavi Patil</span></html> |NABL-133|  +|32|:::| |  
-|25|:::| |  +|33|<html><span style="font-size:150%;">Dr Jahnavi Patil</span></html> |NABL-133|  
-|26|:::| | +|34|:::| |  
 +|35|:::| | 
 |27|:::| |  |27|:::| | 
 |28|:::| |  |28|:::| | 
Line 49: Line 49:
 |28|:::|Hartnup disease|{{ ::hartnup_s_disease_-_new.pptx.pdf |}}| |28|:::|Hartnup disease|{{ ::hartnup_s_disease_-_new.pptx.pdf |}}|
 |29|:::|IQC|{{ ::iqc_janki.ppt.pdf |}}| |29|:::|IQC|{{ ::iqc_janki.ppt.pdf |}}|
-|30|:::| |  +|30|:::|Risk factor of Atherosclerosis |{{ ::risk_factors_for_atherosclerosis_1_.pptx |}} | 
-|31|<html><span style="font-size:150%;">Dr Nishit Chudasama</span></html> | | +|31|:::|Prevention of Atherosclerosis |{{ ::prevention_of_atherosclerosis.pptx |}} | 
-|31|<html><span style="font-size:150%;">Dr Shivam</span></html> | |+|32|:::|Little Rascal - Lipoprotein-a |{{ ::lipoprotein_a_1_.pptx |}} |  
 +|33|:::|Mitochondrial DNA |{{ ::mitochondrial_dna.pptx |}} |  
 +|34|<html><span style="font-size:150%;">Dr Nishit Chudasama</span></html> | | 
 +|35|<html><span style="font-size:150%;">Dr Shivam</span></html> | |
  
 =====Model Questions List For MD Biochemistry===== =====Model Questions List For MD Biochemistry=====
  • md_biochemistry.1782480358.txt.gz
  • Last modified: 2026/06/26 13:25
  • by admin